Surgeon Larissa Temple
Support
By Maureen Salamon, BA, Freelance Writer  |  Thursday, February 26, 2015

A new online survey aims to provide doctors with real-time information on their patients’ quality of life after rectal surgery.

Pictured: Michael Zelefsky
In the Clinic
By Eva Kiesler, PhD and Jim Stallard, MA
Monday, February 2, 2015

Researchers call for intensified efforts to help men with prostate cancer quit smoking after a recent MSK study revealed that patients who smoke during radiation therapy face a higher risk of both having the disease return and dying from it.

Epigenetics
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, January 30, 2015

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, January 28, 2015

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

Pictured: Jaspreet Sandhu and Laura Leddy
Support
By Jennifer Castoro, BA, Managing/Copy Editor  |  Monday, January 26, 2015

Urinary problems like incontinence and overactive bladder can be an issue for cancer survivors. At MSK, our surgeons can offer a range of solutions.

Pictured: José Baselga
Video
By Memorial Sloan Kettering  |  Thursday, January 15, 2015

MSK Physician-in-Chief José Baselga discusses the amazing progress that has been made in fighting cancer.

Dentist Sae Hee Kim
Support
By Maureen Salamon, BA, Freelance Writer  |  Thursday, January 8, 2015

MSK dentist Sae Hee Kim discusses how cancer treatment can affect the teeth and gums and offers tips on how people with cancer can care for them.

Sandra D’Angelo and Jedd Wolchok
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Tuesday, January 6, 2015

A new treatment for advanced melanoma is the latest promising advance in immunotherapy tested in large part by our scientists.

Pictured: Peter Kingham
Perspective
By Peter Kingham, MD, Surgical Oncologist  |  Monday, December 15, 2014

Memorial Sloan Kettering’s top cancer specialists come together to consult on complex cases at weekly Disease Management Team meetings.

Pictured: Eytan Stein
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 11, 2014

An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

Limb lengthening
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Wednesday, November 26, 2014

Memorial Sloan Kettering has taken the lead in applying a limb-lengthening technique in people with bone cancer to restore long gaps in bone after removal of a tumor.

Pictured: William Alago
Q&A
By Maureen Salamon, BA, Freelance Writer  |  Monday, November 24, 2014

Interventional radiologist William Alago discusses minimally invasive procedures, advances in imaging techniques, and the future of his field.

Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 20, 2014

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 17, 2014

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, November 12, 2014

MSK lung cancer patients benefit from a powerful genomic test that looks for mutations in 341 genes to help determine the best treatment.

Center News

Stay Informed

Get the latest information about cancer care and research every month.